Pulse Biosciences completes patient enrollment for cardiac catheter study
Pulse Biosciences reached its enrollment target of 164 evaluable patients for the NANOPULSE-AF IDE pivotal study of its nPulse cardiac catheter system for atrial fibrillation.
Pulse Biosciences reached its enrollment target of 164 evaluable patients for the NANOPULSE-AF IDE pivotal study of its nPulse cardiac catheter system for atrial fibrillation.